Saurabh Shah

1.7k total citations
76 papers, 1.3k citations indexed

About

Saurabh Shah is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Saurabh Shah has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Biomaterials and 21 papers in Biomedical Engineering. Recurrent topics in Saurabh Shah's work include Nanoparticle-Based Drug Delivery (22 papers), RNA Interference and Gene Delivery (16 papers) and Nanoplatforms for cancer theranostics (15 papers). Saurabh Shah is often cited by papers focused on Nanoparticle-Based Drug Delivery (22 papers), RNA Interference and Gene Delivery (16 papers) and Nanoplatforms for cancer theranostics (15 papers). Saurabh Shah collaborates with scholars based in India, United States and United Kingdom. Saurabh Shah's co-authors include Saurabh Srivastava, Shashi Bala Singh, Paras Famta, Nagarjun Rangaraj, Dharmendra Kumar Khatri, Rajeev Singh Raghuvanshi, Sunitha Sampathi, Ganesh Vambhurkar, Dadi A. Srinivasarao and Naitik Jain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Brain Research.

In The Last Decade

Saurabh Shah

73 papers receiving 1.3k citations

Peers

Countries citing papers authored by Saurabh Shah

Since Specialization

Citations

This map shows the geographic impact of Saurabh Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saurabh Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saurabh Shah more than expected).

Fields of papers citing papers by Saurabh Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saurabh Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saurabh Shah. The network helps show where Saurabh Shah may publish in the future.

Co-authorship network of co-authors of Saurabh Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Saurabh Shah. A scholar is included among the top collaborators of Saurabh Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saurabh Shah. Saurabh Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydroxy propyl β-cyclodextrin complexes of olaparib: Amalgamation of in silico, in vitro and in vivo approaches for bioavailability enhancement 2025 ·Journal of Molecular Structure ·Paras Famta, Saurabh Shah, Abhishek Sharma, Ganesh Vambhurkar, Yogesh Singh, (unknown), Dadi A. Srinivasarao, (unknown), (unknown), Giriraj Pandey, (unknown), Jitender Madan, Saurabh Srivastava	1
2	Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics 2024 ·Journal of Drug Delivery Science and Technology ·Saurabh Shah, Paras Famta, Dadi A. Srinivasarao, (unknown), Naitik Jain, (unknown), (unknown), Ganesh Vambhurkar, Giriraj Pandey, Rajendra Kumar, Shailendra Saraf, Saurabh Srivastava	4
3	Nano voyagers: Pioneering a new frontier in cancer treatment with nanorobots as drug transporters 2024 ·Applied Materials Today ·(unknown), (unknown), Dadi A. Srinivasarao, Saurabh Shah, Paras Famta, (unknown), Giriraj Pandey, Ganesh Vambhurkar, (unknown), Rahul Kumar, Saurabh Srivastava	6
4	Coamorphous systems of rebamipide: Selection of amino acid coformers based on protein-ligand docking, in vitro assessment and study of interactions by computational and multivariate analysis 2024 ·International Journal of Pharmaceutics ·Abhishek Sharma, (unknown), (unknown), Saurabh Shah, (unknown), Saurabh Srivastava, Amol G. Dikundwar	2
5	Nanoparticle-enhanced delivery of resveratrol for targeted therapy of glioblastoma: Modulating the Akt/GSK-3β/NF-kB pathway in C6 glioma cells 2024 ·Brain Research ·Gurpreet Singh, Paras Famta, Saurabh Shah, Ganesh Vambhurkar, Giriraj Pandey, (unknown), (unknown), (unknown), Jitender Madan, Saurabh Srivastava, Dharmendra Kumar Khatri	10
6	Exploration of multi-layered nanofiber adjuvant implants of doxorubicin and resveratrol to prevent post-surgery tumor recurrence and invasion 2024 ·Journal of Drug Delivery Science and Technology ·Paras Famta, Saurabh Shah, Anamika Sharma, Giriraj Pandey, Ganesh Vambhurkar, Dadi A. Srinivasarao, Amit Asthana, (unknown), Saurabh Srivastava	14
7	Simvastatin-loaded gelatin-capped polycaprolactone nanoparticles for the post-operative management of breast cancer 2024 ·Journal of Drug Delivery Science and Technology ·Paras Famta, Saurabh Shah, Dadi A. Srinivasarao, Anamika Sharma, (unknown), Ganesh Vambhurkar, Giriraj Pandey, (unknown), (unknown), Amit Asthana, (unknown), (unknown), Dilip Kumar Arya, P.S. Rajinikanth, Saurabh Srivastava	8
8	Exploration of Abiraterone acetate loaded Nanostructured lipid carriers for bioavailability improvement and circumvention of fast-fed variability 2024 ·Drug Delivery and Translational Research ·Saurabh Shah, Paras Famta, Ganesh Vambhurkar, Abhishek Sharma, (unknown), Dadi A. Srinivasarao, (unknown), (unknown), Giriraj Pandey, Jitender Madan, Saurabh Srivastava	3
9	Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancer 2023 ·Life Sciences ·(unknown), Paras Famta, Dadi A. Srinivasarao, Ganesh Vambhurkar, Naitik Jain, Giriraj Pandey, (unknown), (unknown), Saurabh Shah, Shashi Bala Singh, Rajeev Singh Raghuvanshi, Saurabh Srivastava	17
10	Unravelling the potential of microbots in cancer therapy 2023 ·Applied Materials Today ·Saurabh Shah, Paras Famta, Dadi A. Srinivasarao, (unknown), Naitik Jain, Ganesh Vambhurkar, Shashi Bala Singh, Saurabh Srivastava	2
11	Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), Naitik Jain, Paras Famta, Saurabh Shah, Ganesh Vambhurkar, Valencia Fernandes, Dharmendra Kumar Khatri, Shashi Bala Singh, Saurabh Srivastava	23
12	Nanocarrier-based drug delivery via cell-hitchhiking: Emphasizing pharmacokinetic perspective towards taming the “big-old” tumors 2023 ·Journal of Drug Delivery Science and Technology ·Paras Famta, Saurabh Shah, Naitik Jain, Dadi A. Srinivasarao, Ganesh Vambhurkar, (unknown), (unknown), Tausif Ahmed, Giriraj Pandey, Anamika Sharma, Shashi Bala Singh, Saurabh Srivastava	11
13	‘Nano-in-nano’ – Breaching the barriers of the tumor microenvironment using nanoparticle-incorporated nanofibers 2023 ·Journal of Drug Delivery Science and Technology ·Giriraj Pandey, Saurabh Shah, (unknown), (unknown), (unknown), Paras Famta, Naitik Jain, Dadi A. Srinivasarao, Amit Asthana, Rajeev Singh Raghuvanshi, Saurabh Srivastava	15
14	Aptamer guided nanomedicine strategies in prostate cancer: Targeting and diagnosis 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), Naitik Jain, Saurabh Shah, Paras Famta, Dadi A. Srinivasarao, Dharmendra Kumar Khatri, Amit Asthana, Shashi Bala Singh, Rajeev Singh Raghuvanshi, Saurabh Srivastava	6
15	Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability 2023 ·Drug Delivery and Translational Research ·Saurabh Shah, Paras Famta, Ganesh Vambhurkar, (unknown), (unknown), Dadi A. Srinivasarao, (unknown), Anamika Sharma, (unknown), Naitik Jain, Dharmendra Kumar Khatri, Saurabh Srivastava	3
16	Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability in prostate cancer 2023 ·Journal of Drug Delivery Science and Technology ·Saurabh Shah, Paras Famta, Ganesh Vambhurkar, Dadi A. Srinivasarao, (unknown), (unknown), (unknown), Anamika Sharma, Naitik Jain, (unknown), Gurpreet Singh, (unknown), (unknown), Dharmendra Kumar Khatri, Saurabh Srivastava	8
17	Lived Experiences of Bereaved Family Members During COVID-19 Pandemic in a Tertiary Care Hospital With Special Reference to Imposed Restrictive COVID Guidelines—a Qualitative Study 2022 ·OMEGA - Journal of Death and Dying ·(unknown), (unknown), (unknown), Saurabh Shah	4
18	Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications 2021 ·Colloids and Interface Science Communications ·Saurabh Shah, Paras Famta, Rajeev Singh Raghuvanshi, Shashi Bala Singh, Saurabh Srivastava	75
19	Impact of Quality Rights Gujarat program on dropout rate of patients visiting outpatient psychiatry department of tertiary care hospital 2017 ·Asian Journal of Psychiatry ·(unknown), (unknown), (unknown), Saurabh Shah, Soumitra Pathare, (unknown), (unknown)	5
20	Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India – a cross-sectional study 2017 ·International Journal of Psychiatry in Clinical Practice ·(unknown), Parvati B. Patel, (unknown), Tejas Patel, Saurabh Shah, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact